Anti‐S100A4 monoclonal antibody treatment ameliorates experimental skin fibrosis and SSc‐specific transcriptional signatures in human skin: Comment on the targeting S100A4 is helpful in SSc treatment by Trinh‐Minh et al

Saved in:
Bibliographic Details
Published in:Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2024-07, Vol.76 (7), p.1164-1165
Main Authors: Huang, An‐Fang, Xu, Wang‐Dong
Format: Article
Language:English
Subjects:
Animals
Antibodies, Monoclonal - pharmacology
Antibodies, Monoclonal - therapeutic use
Fibrosis
Humans
Monoclonal antibodies
S100 Calcium-Binding Protein A4 - genetics
S100 Calcium-Binding Protein A4 - metabolism
S100A4 protein
Scleroderma, Systemic - drug therapy
Scleroderma, Systemic - immunology
Skin - drug effects
Skin - metabolism
Skin - pathology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2326-5191
2326-5205
2326-5205
DOI:10.1002/art.42824